Microbiota dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82Rubidium PET/CT
Conclusions In this first study of the possible influence of the microbiota dependent metabolite, TMAO, on myocardial perfusion in well-treated HIV-infected patients we found no evidence to suggest that TMAO plays a role in the pathogenesis of coronary heart disease among HIV-infected patients.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Knudsen, A., Troeseid, M., Christensen, T. E., Ghotbi, A., Hasbak, P., Lebech, A.-M., Ripa, R., Kjaer, A. Tags: Cardiovascular Clinical Science: Myocardial Perfusion, Function and Viability Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Coronary Heart Disease | Heart | Heart Attack | Heart Disease | Nuclear Medicine | Pathology | Perfusion | Radiology | Science | Smokers | Statin Therapy | Statistics | Study | Translocation | Trimethylamine | Women